Revisiting the Low-Dose Aspirin Benefit-Risk Discussion in the Context of New Risk Assessment Tools
Lipoprotein(a) in Clinical Practice: From Risk Marker to Actionable Signal
Severe Hypertriglyceridemia to Familial Chylomicronemia Syndrome: Roadmap to Reduce Pancreatitis
A New Era in the Management of T2D: Automated Insulin Delivery
From Needles to Tablets: Integrating Oral Treatments Into Obesity Care
Nonsteroidal MRAs for Patients With Cardiovascular-Kidney-Metabolic Syndrome
Beyond the Usual Suspects: Hypercortisolism as a Key Cause of Resistant Hypertension
The Contributions of Dairy Foods to Cardiometabolic Health
Breaking Through Difficult-to-Control T2D: Targeting Hypercortisolism
Beyond PPIs: New Options for Treating GERD
Comprehensive Obesity Management Part 1: Assessment and Initiation of Treatment
Comprehensive Obesity Management Part 2: Ongoing Assessment and Individualization of the Treatment Plan
Case Studies in Continuous Glucose Monitoring
Hypercortisolism is More Common Than You Think—Here's How to Find It
The Role of Finerenone in Optimizing Cardiovascular-Kidney-Metabolic Health: Everything PCPs Should Know
What Primary Care Clinicians Need to Know About Once-Weekly Insulins